Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1984 1
1985 1
1986 1
1988 1
1990 1
1991 1
1993 1
1994 1
1995 3
1996 2
1999 3
2000 1
2001 1
2002 1
2003 1
2004 2
2005 2
2006 8
2007 5
2008 4
2009 2
2010 1
2011 3
2012 2
2013 6
2014 3
2015 4
2016 6
2017 5
2018 6
2019 5
2020 7
2021 4
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
The benefits and harms of breast cancer screening: an independent review.
Independent UK Panel on Breast Cancer Screening. Independent UK Panel on Breast Cancer Screening. Lancet. 2012 Nov 17;380(9855):1778-86. doi: 10.1016/S0140-6736(12)61611-0. Epub 2012 Oct 30. Lancet. 2012. PMID: 23117178 Free article. Review.
In a meta-analysis, estimates of the excess incidence were 11% (95% CI 9-12) when expressed as a proportion of cancers diagnosed in the invited group in the long term, and 19% (15-23) when expressed as a proportion of the cancers diagnosed during the active screening perio …
In a meta-analysis, estimates of the excess incidence were 11% (95% CI 9-12) when expressed as a proportion of cancers diagnosed in the invi …
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
We report effects on breast cancer outcomes among the 6846 women with ER-positive disease, and side-effects among all women (with positive, negative, or unknown ER status). Long-term follow-up still continues. This study is registered, number ISRCTN19652633. ...
We report effects on breast cancer outcomes among the 6846 women with ER-positive disease, and side-effects among all women (with positive, …
Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial.
Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, Smith D; Magpie Trial Collaboration Group. Altman D, et al. Lancet. 2002 Jun 1;359(9321):1877-90. doi: 10.1016/s0140-6736(02)08778-0. Lancet. 2002. PMID: 12057549 Clinical Trial.
Evidence supported magnesium sulphate as the drug to evaluate. METHODS: Eligible women (n=10141) had not given birth or were 24 h or less postpartum; blood pressure of 140/90 mm Hg or more, and proteinuria of 1+ (30 mg/dL) or more; and there was clinical uncertainty about …
Evidence supported magnesium sulphate as the drug to evaluate. METHODS: Eligible women (n=10141) had not given birth or were 24 h or …
Improving the reporting of pragmatic trials: an extension of the CONSORT statement.
Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D; CONSORT group; Pragmatic Trials in Healthcare (Practihc) group. Zwarenstein M, et al. Among authors: altman dg. BMJ. 2008 Nov 11;337:a2390. doi: 10.1136/bmj.a2390. BMJ. 2008. PMID: 19001484 Free PMC article.
The applicability of a trial's results (generalisability or external validity) is also important, particularly for pragmatic trials. A pragmatic trial (a term first used in 1967 by Schwartz and Lellouch) can be broadly defined as a randomised controlled trial whose purpose …
The applicability of a trial's results (generalisability or external validity) is also important, particularly for pragmatic trials. A pragm …
Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.
Copson ER, Maishman TC, Tapper WJ, Cutress RI, Greville-Heygate S, Altman DG, Eccles B, Gerty S, Durcan LT, Jones L, Evans DG, Thompson AM, Pharoah P, Easton DF, Dunning AM, Hanby A, Lakhani S, Eeles R, Gilbert FJ, Hamed H, Hodgson S, Simmonds P, Stanton L, Eccles DM. Copson ER, et al. Among authors: altman dg. Lancet Oncol. 2018 Feb;19(2):169-180. doi: 10.1016/S1470-2045(17)30891-4. Epub 2018 Jan 11. Lancet Oncol. 2018. PMID: 29337092 Free PMC article.
Clinicopathological data, and data regarding treatment and long-term outcomes, including date and site of disease recurrence, were collected from routine medical records at 6 months, 12 months, and then annually until death or loss to follow-up. ...A prespecified subgroup …
Clinicopathological data, and data regarding treatment and long-term outcomes, including date and site of disease recurrence, were co …
Reporting of randomized factorial trials was frequently inadequate.
Kahan BC, Tsui M, Jairath V, Scott AM, Altman DG, Beller E, Elbourne D. Kahan BC, et al. Among authors: altman dg. J Clin Epidemiol. 2020 Jan;117:52-59. doi: 10.1016/j.jclinepi.2019.09.018. Epub 2019 Oct 1. J Clin Epidemiol. 2020. PMID: 31585174 Review.
Inappropriate methods of analysis to protect against potential negative effects from interactions were common, with 18 trials (18%) choosing the analysis method based on a preliminary test for interaction, and 13% (n = 10/75) of those conducting a factorial analysis including an …
Inappropriate methods of analysis to protect against potential negative effects from interactions were common, with 18 trials (18%) choosing …
AKI and Long-Term Risk for Cardiovascular Events and Mortality.
Odutayo A, Wong CX, Farkouh M, Altman DG, Hopewell S, Emdin CA, Hunn BH. Odutayo A, et al. Among authors: altman dg. J Am Soc Nephrol. 2017 Jan;28(1):377-387. doi: 10.1681/ASN.2016010105. Epub 2016 Jun 13. J Am Soc Nephrol. 2017. PMID: 27297949 Free PMC article. Review.
AKI associates with increased long-term risk of mortality, but the prognostic significance of AKI in terms of long-term cardiovascular disease remains unconfirmed. We conducted a systematic review and meta-analysis to assess whether AKI associates with long-term …
AKI associates with increased long-term risk of mortality, but the prognostic significance of AKI in terms of long-term cardio …
Health education intervention strategies: recommendations for future research.
Steckler A, Allegrante JP, Altman D, Brown R, Burdine JN, Goodman RM, Jorgensen C. Steckler A, et al. Among authors: altman d. Health Educ Q. 1995 Aug;22(3):307-28. doi: 10.1177/109019819402200305. Health Educ Q. 1995. PMID: 7591787 Review.
Because health education interventions work through intermediate outcomes, the linkage to health status is often assumed to be at a conceptual or theoretical level. The term health education intervention strategy is a heuristic device used to conceptualize and organize a l …
Because health education interventions work through intermediate outcomes, the linkage to health status is often assumed to be at a conceptu …
88 results